NEW YORK--(BUSINESS WIRE)--Kirby McInerney LLP is investigating potential claims against the Board of Directors of Thoratec Corporation (“Thoratec” or the “Company”) (NASDAQ:THOR) concerning the proposed acquisition of the Company by St. Jude Medical, Inc. Pursuant to the terms of the definitive agreement, Thoratec stockholders will receive $63.50 in cash for each share of Thoratec common stock they own, in a transaction valued at approximately $3.4 billion. The investigation concerns whether t
| < Prev | Next > |
|---|
